SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

CECONI, Claudio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.095
AS - Asia 7.724
EU - Europa 5.416
SA - Sud America 1.413
AF - Africa 104
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 5
Totale 33.787
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 18.856
SG - Singapore 3.243
CN - Cina 2.247
IT - Italia 1.814
UA - Ucraina 1.261
BR - Brasile 1.212
HK - Hong Kong 807
DE - Germania 678
TR - Turchia 589
GB - Regno Unito 504
VN - Vietnam 372
FI - Finlandia 310
RU - Federazione Russa 277
SE - Svezia 194
MX - Messico 136
AR - Argentina 85
FR - Francia 83
ID - Indonesia 81
CA - Canada 76
IN - India 71
PL - Polonia 66
BD - Bangladesh 63
JP - Giappone 46
ZA - Sudafrica 46
AT - Austria 41
ES - Italia 40
IQ - Iraq 39
EC - Ecuador 37
NL - Olanda 35
AU - Australia 21
KR - Corea 18
CL - Cile 17
CO - Colombia 17
GE - Georgia 17
UZ - Uzbekistan 17
VE - Venezuela 17
LT - Lituania 16
MA - Marocco 14
PK - Pakistan 13
EG - Egitto 12
PY - Paraguay 12
BE - Belgio 11
CZ - Repubblica Ceca 10
KE - Kenya 10
AE - Emirati Arabi Uniti 9
IE - Irlanda 9
PE - Perù 9
AL - Albania 8
IR - Iran 8
RO - Romania 8
BG - Bulgaria 7
PH - Filippine 7
SA - Arabia Saudita 7
TN - Tunisia 7
TW - Taiwan 7
CH - Svizzera 6
JM - Giamaica 6
JO - Giordania 6
LB - Libano 6
NP - Nepal 6
NZ - Nuova Zelanda 6
PT - Portogallo 6
UY - Uruguay 6
EU - Europa 5
IL - Israele 5
KG - Kirghizistan 5
MY - Malesia 5
RS - Serbia 5
TH - Thailandia 5
BY - Bielorussia 4
GT - Guatemala 4
HR - Croazia 4
PS - Palestinian Territory 4
SN - Senegal 4
AM - Armenia 3
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CR - Costa Rica 3
GR - Grecia 3
HN - Honduras 3
KZ - Kazakistan 3
MD - Moldavia 3
OM - Oman 3
TT - Trinidad e Tobago 3
AZ - Azerbaigian 2
HU - Ungheria 2
KH - Cambogia 2
MM - Myanmar 2
NI - Nicaragua 2
NO - Norvegia 2
TG - Togo 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
CG - Congo 1
CI - Costa d'Avorio 1
CY - Cipro 1
DK - Danimarca 1
Totale 33.768
Salva come PNG Salva come JPEG
Città #
Woodbridge 2.376
Fairfield 2.367
Singapore 1.825
Ashburn 1.442
Houston 1.362
Jacksonville 1.348
Seattle 990
Chandler 887
Ann Arbor 886
Wilmington 809
Hong Kong 800
Cambridge 795
Santa Clara 644
Beijing 511
Dallas 498
Izmir 432
Nanjing 410
Princeton 349
San Diego 232
Boardman 197
Milan 148
Los Angeles 144
Ho Chi Minh City 138
Shenyang 135
New York 130
Nanchang 119
Moscow 111
Rome 109
Hefei 101
Mexico City 94
São Paulo 93
Hebei 81
San Mateo 76
Changsha 75
Falls Church 68
Ferrara 68
Jiaxing 67
Hanoi 65
Tianjin 65
Warsaw 59
Jinan 58
Shanghai 57
London 55
Chicago 54
Munich 52
Naples 50
Zhengzhou 48
Mountain View 47
Verona 44
Ningbo 40
Bremen 38
Jakarta 38
Redwood City 37
Taizhou 37
Rio de Janeiro 35
Tokyo 35
The Dalles 33
Brooklyn 30
Philadelphia 30
Helsinki 27
Norwalk 27
Addison 25
Tappahannock 25
Johannesburg 24
Napoli 24
Columbus 22
Guangzhou 22
Indiana 22
Toronto 22
Belo Horizonte 21
Hangzhou 21
Stockholm 21
Falkenstein 20
Frankfurt am Main 20
Kunming 20
Montreal 20
San Jose 20
Brasília 19
Campinas 19
Porto Alegre 19
Turku 19
Washington 19
Des Moines 18
Guarulhos 18
Orange 18
Turin 18
Atlanta 17
Bari 17
Buffalo 17
Council Bluffs 17
Haiphong 17
Nuremberg 17
Tashkent 17
Tbilisi 17
Bologna 16
Chennai 16
Goiânia 16
Lappeenranta 16
Salt Lake City 16
Da Nang 15
Totale 22.725
Salva come PNG Salva come JPEG
Nome #
IL METABOLISMO DEL MIOCARDIO ISCHEMICO IBERNATO E STORDITO: DIFFERENZA TRA NECROSI E APOPTOSI 1.805
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012 248
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines 213
Echocardiography, Spirometry, and Systemic Acute-Phase Inflammatory Proteins in Smokers with COPD or CHF: An Observational Study 212
2015 ESC Guidelines for the diagnosis and management of pericardial diseases The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC) Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) 210
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes 206
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management 206
Abnormalities of Left Ventricular Function in Asymptomatic Patients with Systemic Sclerosis Using Doppler Measures of Myocardial Strain 201
Uric acid and coronary artery disease: An elusive link deserving further attention 200
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC 200
ACE inhibition modulates endothelial apoptosis and renewal via endothelial progenitor cells in patients with acute coronary syndromes (Am Journal of Cardiovasc Drugs (2011) 11:3 (189-98)) 190
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals 190
Effects of temperature on myocardial calcium homeostasis and mitochondrial function during ischemia and reperfusion 189
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL 187
Cardiac troponin elevation predicts all-cause mortality in patients with acute exacerbation of chronic obstructive pulmonary disease: Systematic review and meta-analysis 186
Incremental exercise using progressive versus constant pedaling rates: A study in cardlac patients 185
2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation * Developed with the special contribution of the European Heart Rhythm Association. 181
The combined effect of subcutaneous granulocyte- colony stimulating factor and myocardial contrast echocardiography with intravenous infusion of sulfur hexafluoride on post-infarction left ventricular function, the RIGENERA 2.0 trial: Study protocol for a randomized controlled trial 172
Prolonged propionyl-L-carnitine pre-treatment of rabbit: Biochemical, hemodynamic and electrophysiological effects on myocardium 171
Enhanced expression and activity of xanthine oxidoreductase in the failing heart. 168
Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention 166
ACE inhibition with perindopril and biomarkers of atherosclerosis and thrombosis: Results from the PERTINENT study 163
The ACE-inhibitor Perindoprilat has high selectivity for bradykinin binding sites of human somatic ACE 161
Link between chronic obstructive pulmonary disease and coronary artery disease: Implication for clinical practice 161
Third Universal Definition of Myocardial Infarction 161
Guidelines on myocardial revascularization 160
Therapeutic effects of L-carnitine and propionyl-L-carnitine on cardiovascular diseases: a review 160
Multiparametric flow cytometric characterization of circulating stem cell subsets in patients with myocardial infarction: correlation with clinical and biological data 159
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). 159
Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) 158
Tumor necrosis factor-α receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: The cytokine-activation and long-term prognosis in myocardial infarction (C-ALPHA) study 157
Relationship between Troponin Elevation, Cardiovascular History and Adverse Events in Patients with acute exacerbation of COPD 157
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation 155
Angiotensin-converting enzyme (ACE) inhibitors have different selectivity for bradykinin binding sites of human somatic ACE 155
Reduction of oxidative stress by carvedilol: Role in maintenance of ischaemic myocardium viability 154
Is stunning an important component of preconditioning? 154
Advanced glycation end products and its soluble receptor (sRAGE) are increased in chronic heart failure but not in chronic obstructive pulmonary disease. 154
Non-insulin antidiabetic pharmacotherapy in patients with established cardiovascular disease: a position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy 154
Postinfarction Left Ventricular Free Wall Rupture: Original Management and Surgical Technique 153
[Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI] 152
Time course of human atrial natriuretic factor release during cardiopulmonary bypass in mitral valve and coronary artery diseased patients 151
Specific properties and effect of perindopril in controlling the renin-angiotensin system 151
Neglected COPD and chronic comorbidities in elderly patients with chronic heart failure 149
Bradykinin and coronary artery disease 149
[Comparative protective effect of gallopamil in myocardial ischemia and reperfusion] 149
Occurrence of oxidative stress during reperfusion of the human heart 148
Activation of the neuroendocrine response in heart failure: adaptive or maladaptive process? 148
[The double face of oxygen. An introduction to cardiac pathology caused by oxidation injury] 147
Effects of endotoxic shock on neuronal NOS and calcium transients in rat cardiac myocytes 147
Traditional and new composite endpoints in heart failure clinical trials: Facilitating comprehensive efficacy assessments and improving trial efficiency 147
Effects of iloprost (ZK 36374) on glutathione status during ischaemia and reperfusion of rabbit isolated hearts 146
Effect of superoxide generation on rat heart mitochondrial pyruvate utilization 146
Long-term treatment with ivabradine in post-myocardial infarcted rats counteracts f-channel overexpression 146
Neuroendocrine Control of the Cardiovascular System in Heart Failure 146
Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease 146
Evidence against malondialdehyde bound to cellular constituents in phospholipid peroxidation 146
Oxygen free radicals and myocardial damage: Protective role of thiol-containing agents 145
Myocardial damage during ischaemia and reperfusion 145
In vitro administration of ergothioneine failed to protect isolated ischaemic and reperfused rabbit heart 145
Ischemic Heart Disease. 130 Questions & Answers 144
Differences in the effect of angiotensin-converting enzyme inhibitors on the rate of endothelial cell apoptosis: in vitro and in vivo studies 144
Pathophysiological role of heart rate: from ischaemia to left ventricular dysfunction 144
Third Universal Definition of Myocardial Infarction 144
[Heart failure: an endothelial disorder?] 143
Right heart failure chronically stimulates heat shock protein 72 in heart and liver but not in other tissues. 143
Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? 142
Differential action of ACE inhibitors on the eNOS pathway 142
Different outcomes of the reperfused myocardium: insights into the comments of stunning and hibernation. 141
Secondary Prevention of CAD with ACE Inhibitors: A Struggle Between Life and Death of the Endothelium 141
Plasma levels of atrial natriuretic factor and urinary excretion of arginine vasopressin and catecholamines in children with congenital heart disease effect of cardiac surgery 140
The effect of propionyl-L-carnitine on the ischemic and reperfused intact myocardium and on their derived mitochondria 140
Chromogranin A in heart failure - A novel neurohumoral factor and a predictor for mortality 140
Angiotensin II overproduction: enemy of the vessel wall 140
Relevance of apoptosis in influencing recovery of hibernating myocardium 140
New insights on myocardial pyridine nucleotides and thiol redox state in ischemia and reperfusion damage 139
Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: Experimental studies 139
Different sites of action of diltiazem, nifedipine and verapamil on myocardial, coronary and aortic muscle 139
Selective and specific I f inhibition with ivabradine: New perspectives for the treatment of cardiovascular disease 139
Oxygen Free Radicals in Shock 139
Oxygen free radicals and reperfusion injury; the effect of ischaemia and reperfusion on the cellular ability to neutralise oxygen toxicity 138
Heart rate reduction by pharmacological If current inhibition 138
Efficacy of Ivabradine in Combination with Beta-Blocker Versus Uptitration of Beta-Blocker in Patients with Stable Angina 138
Specific and selective I-f inhibition: expected clinical benefits from pure heart rate reduction in coronary patients 138
The occurrence of oxidative stress during reperfusion in experimental animals and men 137
Anti-ischaemic effect of ivabradine 137
ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). 137
Heart rate reduction with ivabradine prevents the global phenotype of left ventricular remodeling. 137
Effect of thalidomide on the skeletal muscle in experimental heart failure 137
Skeletal muscle abnormalities in rats with experimentally induced heart hypertrophy and failure 136
Protective effect of propionyl-L-carnitine against ischaemia and reperfusion-damage 136
Metabolic changes during post-ischaemic reperfusion. 136
Effect of ivabradine on structural and electrophysiological remodelling in a rat model of heart failure 136
Effect of D-600 on ischemic and reperfused rabbit myocardium: relation with timing and modality of administration. 136
Revascularization of hibernating myocardium: Rate of metabolic and functional recovery and occurrence of oxidative stress 135
Third universal definition of myocardial infarction 135
Oxidative stress during myocardial ischaemia and reperfusion: Experimental and clinical evidences 135
Potential prognostic significance of decreased serum levels of TRAIL after acute myocardial infarction 135
Cardioprotection by nisoldipine: Role of timing of administration 134
The influence of right heart catheterisation on pulmonary arterial pressure in chronic heart failure: relationship to neuroendocrinal changes 134
Guidelines for the diagnosis and treatment of pulmonary hypertension: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT). 134
Totale 17.152
Salva come PNG Salva come JPEG
Categoria #
all - tutte 152.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 6.560
Totale 158.770
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.895 0 0 0 0 0 362 78 437 76 438 353 151
2021/20222.999 85 374 306 82 107 137 167 151 100 187 262 1.041
2022/20232.315 277 29 78 259 391 382 52 243 315 24 152 113
2023/20241.176 178 166 77 50 66 130 48 31 18 64 56 292
2024/20254.108 83 106 341 104 527 279 138 304 693 545 480 508
2025/20266.700 1.001 540 1.422 1.663 1.420 654 0 0 0 0 0 0
Totale 34.033